Detailed View
IDXX - IDEXX Laboratories, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
39,760,830,464
Adj EBIT (TTM)
1,521,575,000
Enterprise Value
40,013,761,464
Last Price
504.70
Earnings Yield
3.80%
Return on Capital
92.47%
Capital
1,645,555,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 1,216,585,000 | 425,566,000 |
| 2026-03-31 | 10-Q | 2026 | 1,140,820,000 | 362,586,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 1,090,579,000 | 315,605,000 |
| 2025-09-30 | 10-Q | 2025 | 1,105,239,000 | 354,846,000 |
| 2025-06-30 | 10-Q | 2025 | 1,109,457,000 | 373,046,000 |
| 2025-03-31 | 10-Q | 2025 | 998,427,000 | 316,534,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 954,288,000 | 261,686,000 |
| 2024-09-30 | 10-Q | 2024 | 975,543,000 | 303,892,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.